Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity

[1]  P. Cohen,et al.  Glycogen Synthase from Rabbit Skeletal Muscle , 2005 .

[2]  P. Cohen,et al.  Glycogen synthase from rabbit skeletal muscle; effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo. , 2005, European journal of biochemistry.

[3]  S. Semiz,et al.  Effects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats , 2002, Molecular and Cellular Biochemistry.

[4]  J. Hawley,et al.  Postexercise muscle glycogen resynthesis in obese insulin-resistant Zucker rats. , 2001, Journal of applied physiology.

[5]  A. Depaoli-Roach,et al.  Insulin Control of Glycogen Metabolism in Knockout Mice Lacking the Muscle-Specific Protein Phosphatase PP1G/RGL , 2001, Molecular and Cellular Biology.

[6]  J. McNeill,et al.  Mechanisms of vanadium action: insulin-mimetic or insulin-enhancing agent? , 2000, Canadian journal of physiology and pharmacology.

[7]  R. Henry,et al.  Protein Kinase Cθ Expression Is Increased upon Differentiation of Human Skeletal Muscle Cells: Dysregulation in Type 2 Diabetic Patients and a Possible Role for Protein Kinase Cθ in Insulin-Stimulated Glycogen Synthase Activity. , 2000, Endocrinology.

[8]  P. Roach,et al.  Glycogen synthase sensitivity to insulin and glucose-6-phosphate is mediated by both NH2- and COOH-terminal phosphorylation sites. , 2000, Diabetes.

[9]  L. Singh,et al.  The effects of glucose and the hexosamine biosynthesis pathway on glycogen synthase kinase-3 and other protein kinases that regulate glycogen synthase activity. , 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[10]  K. Petersen,et al.  Mechanism of muscle glycogen autoregulation in humans. , 2000, American journal of physiology. Endocrinology and metabolism.

[11]  C. Kahn,et al.  Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. , 2000, Metabolism: clinical and experimental.

[12]  S. Mudaliar,et al.  Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. , 2000, Diabetes.

[13]  R. Henry,et al.  Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. , 1999, The Journal of clinical investigation.

[14]  E. Krebs,et al.  Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. , 1999, Diabetes.

[15]  B. Salh,et al.  In vivo regulation of protein-serine kinases by insulin in skeletal muscle of fructose-hypertensive rats. , 1999, American journal of physiology. Endocrinology and metabolism.

[16]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[17]  H. Ortmeyer.  Insulin Increases Liver Protein Phosphatase-1 and Protein Phosphatase-2C Activities in Lean, Young Adult Rhesus Monkeys , 1998, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[18]  W. Choi,et al.  Insulin-stimulated glycogen synthesis in cultured hepatoma cells: differential effects of inhibitors of insulin signaling molecules. , 1998, Journal of receptor and signal transduction research.

[19]  L. Ragolia,et al.  Protein phosphatase-1 and insulin action , 1998, Molecular and Cellular Biochemistry.

[20]  M. Srinivasan,et al.  Glycogen synthase activation in the epididymal adipose tissue from chronic hyperinsulinemic/obese rats , 1998 .

[21]  P. Cohen,et al.  Insulin activates protein kinase B, inhibits glycogen synthase kinase‐3 and activates glycogen synthase by rapamycin‐insensitive pathways in skeletal muscle and adipose tissue , 1997, FEBS letters.

[22]  A. V. Skurat,et al.  Glycogen synthase: activation by insulin and effect of transgenic overexpression in skeletal muscle. , 1997, Biochemical Society transactions.

[23]  A. Kikuchi,et al.  Tyrosine dephosphorylation of glycogen synthase kinase‐3 is involved in its extracellular signal‐dependent inactivation , 1996, FEBS letters.

[24]  H. Shamoon,et al.  Oral Vanadyl Sulfate Improves Insulin Sensitivity in NIDDM but Not in Obese Nondiabetic Subjects , 1996, Diabetes.

[25]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[26]  C. Kahn,et al.  In vivo andin vitro studies of vanadate in human and rodent diabetes mellitus , 1995, Molecular and Cellular Biochemistry.

[27]  C. Kahn,et al.  Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. , 1995, The Journal of clinical endocrinology and metabolism.

[28]  S. Pugazhenthi,et al.  Regulation of glycogen synthase activation in isolated hepatocytes , 1995, Molecular and Cellular Biochemistry.

[29]  H. Shamoon,et al.  Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.

[30]  P. Roach,et al.  Phosphorylation of Sites 3a and 3b (Ser640 and Ser644) in the Control of Rabbit Muscle Glycogen Synthase(*) , 1995, The Journal of Biological Chemistry.

[31]  D. Turnbull,et al.  Inhibition of glycogen synthase kinase-3 by insulin in cultured human skeletal muscle myoblasts. , 1995, Biochemical and biophysical research communications.

[32]  C. R. Kahn,et al.  Insulin Action, Diabetogenes, and the Cause of Type II Diabetes , 1994, Diabetes.

[33]  P. Roach,et al.  Inactivation of rabbit muscle glycogen synthase by glycogen synthase kinase-3. Dominant role of the phosphorylation of Ser-640 (site-3a). , 1993, The Journal of biological chemistry.

[34]  C. Proud,et al.  Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. , 1993, The Biochemical journal.

[35]  B. Hansen,et al.  Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys. , 1993, The American journal of physiology.

[36]  H. Vestergaard,et al.  Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus. , 1993, The Journal of clinical investigation.

[37]  J. McNeill,et al.  In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes. , 1993, Diabetes research and clinical practice.

[38]  A. Vaag,et al.  Insulin Resistance in Skeletal Muscles in Patients With NIDDM , 1992, Diabetes Care.

[39]  C. Bogardus,et al.  Defective insulin response of phosphorylase phosphatase in insulin-resistant humans. , 1992, The Journal of clinical investigation.

[40]  M. Bollen,et al.  Increased synthase phosphatase activity is responsible for the super-activation of glycogen synthase in hepatocytes from fasted obese Zucker rats. , 1991, Endocrinology.

[41]  P. Cohen,et al.  The molecular mechanism by which adrenalin inhibits glycogen synthesis. , 1991, European journal of biochemistry.

[42]  A. Vaag,et al.  Reduced glycogen synthase activity in skeletal muscle from obese patients with and without Type 2 (non-insulin-dependent) diabetes mellitus , 1991, Diabetologia.

[43]  C. Kahn,et al.  Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus. , 1991, The Journal of clinical investigation.

[44]  P. Dent,et al.  The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle , 1990, Nature.

[45]  C. Bogardus,et al.  Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle. , 1990, The Journal of clinical investigation.

[46]  M. Cobb,et al.  An insulin-stimulated ribosomal protein S6 kinase from rabbit liver. , 1989, The Journal of biological chemistry.

[47]  S. Brichard,et al.  Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. , 1989, Endocrinology.

[48]  P. Cohen,et al.  An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues , 1989, FEBS letters.

[49]  W. Benjamin,et al.  Insulin action rapidly decreases multifunctional protein kinase activity in rat adipose tissue. , 1988, The Journal of biological chemistry.

[50]  B. Gibson,et al.  Analysis of the in vivo phosphorylation state of rabbit skeletal muscle glycogen synthase by fast-atom-bombardment mass spectrometry. , 1988, European journal of biochemistry.

[51]  E. Krebs,et al.  Mitogen-activated S6 kinase is stimulated via protein kinase C-dependent and independent pathways in Swiss 3T3 cells. , 1987, The Journal of biological chemistry.

[52]  J. Meyerovitch,et al.  Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action. , 1987, The Journal of biological chemistry.

[53]  P. Cohen,et al.  The protein phosphatases involved in cellular regulation. Evidence that dephosphorylation of glycogen phosphorylase and glycogen synthase in the glycogen and microsomal fractions of rat liver are catalysed by the same enzyme: protein phosphatase-1. , 1986, European journal of biochemistry.

[54]  J. McNeill,et al.  Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. , 1985, Science.

[55]  L. Jefferson,et al.  Protein Phosphatase-1 and -2A Activities in Heart, Liver, and Skeletal Muscle Extracts from Control and Diabetic Rats , 1984, Diabetes.

[56]  R. Mellgren,et al.  Coordinated feedback regulation of muscle glycogen metabolism: inhibition of purified phosphorylase phosphatase by glycogen. , 1983, Biochemical and biophysical research communications.

[57]  P. Cohen,et al.  Glycogen synthase from rabbit skeletal muscle. State of phosphorylation of the seven phosphoserine residues in vivo in the presence and absence of adrenaline. , 1982, European journal of biochemistry.

[58]  P. Cohen,et al.  Glycogen synthase kinase-3 from rabbit skeletal muscle. , 1981, Methods in enzymology.

[59]  C. Villar-Palasi.  OLIGO‐ AND POLYSACCHARIDE INHIBITION OF MUSCLE TRANSFERASE D PHOSPHATASE * , 1969, Annals of the New York Academy of Sciences.

[60]  R. Henry,et al.  Protein kinase Ctheta expression is increased upon differentiation of human skeletal muscle cells: dysregulation in type 2 diabetic patients and a possible role for protein kinase Ctheta in insulin-stimulated glycogen synthase activity. , 2000, Endocrinology.

[61]  H. Beck-Nielsen,et al.  General characteristics of the insulin resistance syndrome: prevalence and heritability. European Group for the study of Insulin Resistance (EGIR). , 1999, Drugs.

[62]  M. Battell,et al.  Acute and chronic oral administration of bis(maltolato)oxovanadium(IV) in Zucker diabetic fatty (ZDF) rats. , 1999, Diabetes research and clinical practice.

[63]  P. Roach,et al.  Multiple mechanisms for the phosphorylation of C-terminal regulatory sites in rabbit muscle glycogen synthase expressed in COS cells. , 1996, The Biochemical journal.

[64]  H. Shamoon,et al.  Erratum: Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects (Diabetes (1996) 45 (659-666)) , 1996 .

[65]  P. Cohen,et al.  Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. , 1980, European journal of biochemistry.